Objectives-The purposes of this study were to verify whether inhalable silicon dioxide (SiO 2 ) nanoparticles could induce hepatic injury and to investigate the relationship between the exposure time and SiO 2 nanoparticle dosage by using acoustic radiation force impulse imaging (ARFI).
D
amage caused by inhalable fine particulate matter has become a rapidly developing topic and the frontier of many investigations surrounding air pollution in recent years. Natural and ultrafine silicon dioxide (SiO 2 ) nanoparticles are known as some of the most important compositions of fine particulate matter. 1, 2 In vitro and in vivo studies have shown that the toxicities posed by nanomaterials include carcinogenicity and damage to the lung, heart, liver, kidney, and nerves, as well as reproductive and immune systems. 3 Whether inhalable SiO 2 nanoparticles in polluted air could induce human liver injury remains unknown. Hence, the potential hazards of inhalable SiO 2 nanoparticles in fine particulate matter to human health warrant further investigation.
We previously reported that a group of patients exposed to SiO 2 nanoparticles and polyacrylate (PPE) had an unusual lung disease and elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. 4 In consideration of this event, we speculated that inhalable SiO 2 nanoparticles, PPE, or an SiO 2 /PPE complex solution may be related to liver injury. However, the mechanism of action and timing for SiO 2 nanoparticle exposure to induce human liver injury remained in question. Furthermore, serum ALT and AST were not direct evidence of hepatic injury. To verify the hepatic toxicity of inhalable SiO 2 nanoparticles, we established a rat model to investigate the role of SiO 2 nanoparticle hepatotoxicity. In this study, SiO 2 nanoparticles with a mean nanoparticle diameter of 20 nm were similar to those found in patients from our previous study.
On the other hand, we tried to find out a noninvasive and effective way to continuously observe the potential hepatic injury in human induced by SiO 2 nanoparticles. With the development of acoustic radiation force impulse imaging (ARFI) in recent years, the shear wave velocity (SWV) had been widely used to quantitatively analyze tissue hardness. Harder hepatic tissue could produce a faster SWV, which has been associated with the degree of chronic liver injury. Many studies had confirmed the efficiency and reproducibility of the SWV in diagnosing liver fibrosis and evaluating the prognosis of chronic liver diseases in vitro and in vivo, with a rising SWV as an indicator of characteristic changes. [5] [6] [7] In this study, ARFI was first used to continuously observe the changes in hepatic stiffness in rats. Furthermore, our study aimed to reveal the relationship between the SWV, exposure time, and SiO 2 nanoparticle dosage.
Materials and Methods

Chemicals and Solution Preparation
Silicon dioxide nanoparticle suspensions in water with a mean diameter of 20 nm (20 6 5 nm) were similar to those found in patients, as well as SiO 2 nanoparticle/ PPE suspensions, which were made from the same silica particles by Fudan University (Shanghai, China). The SiO 2 /PPE composite was prepared by in situ emulsion polymerization. The size and shape of the SiO 2 and PPE/SiO 2 nanoparticles were assessed with a JEM 1400Plus electron microscope (JEOL Ltd, Tokyo, Japan; Figure 1 ). Pentobarbital sodium was obtained from the Beijing Chemical Reagents Company (Beijing, China), which was imported from Germany (batch number 020919); 0.9% normal saline (OTC H1098 3046) was purchased from the Tianjin Baite Medical Supplies Co, Ltd (Tianjin, China).
Freshly prepared SiO 2 nanoparticle suspensions were diluted in 0.9% saline (Tianjin Baite Medical Supplies Co, Ltd) in 25%, 50%, and 100% SiO 2 groups with different concentrations of SiO 2 nanoparticles: 51.2, 102.4, and 204.8/kg. Different concentrations of SiO 2 / PPE suspensions were also made with the same concentrations of SiO 2 nanoparticles.
Animals, Subgroups, and Exposure Method
All experiments were conducted in accordance with the guidelines of Capital Medical University for the care and use of laboratory animals and with the approval of the Animal Ethical Committee of Capital Medical University.
Animals
A total of 72 male specific pathogen-free Wistar rats (220 610 g) were obtained from the Animal Center of Lianhelihua (Beijing, China). Rats were individually housed at a constant temperature (228C 6 18C) and humidity (50% 6 10%) for 12 hours under a 12-hour light/dark cycle with free access to food and water. The rats were acclimated for 1 week on arrival and were handled daily to minimize stress before the treatment.
Subgroups
Seventy-two rats were randomly divided into 9 groups with 8 rats in each group: blank control group, normal saline group, PPE group, 25%, 50%, and 100% SiO 2 groups, and 25%, 50%, and 100% SiO 2 /PPE groups.
Exposure Method
Before use, suspensions were sonicated for 30 minutes and vortexed briefly for 10 minutes to minimize their aggregation (Bioruptor UDC-200; Cosmo Bio, Carlsbad, CA). The suspensions were then introduced directly into each rat by pharyngeal instillation. After being anesthetized with intraperitoneal injection of 0.3% pentobarbital sodium (1 mL/100 g; Beijing Chemical Reagents Company), the rats in the experimental groups were sequentially given different concentrations of SiO 2 or SiO 2 /PPE suspensions by intratracheal instillation at a total amount of 1 mL (0.5 mL into each lung). The positive and negative control groups were sequentially treated with the same amount of PPE or a 0.9% saline suspension. The control group only received food and water. All of the rats were checked daily for general conditions, clinical signs, and abnormal behavior. None of the rats died during the experimental period. The rats were put to death and autopsied on day 28, and the livers were extracted for pathologic examination.
Ultrasound Examinations and Measurements of Hepatic SWV After successful program modeling, the rats were examined with an Acuson S2000 Color Doppler ultrasound system (Siemens Medical Solutions, Mountain View, CA) on days 3, 7, 14, 21, and 28. The hair of the rats was subsequently removed under ether anesthesia. The rats were then placed in a supine position on a mounting plate. A 9L4 linear transducer with a frequency of 8 MHz was located on the right subcostal area, and gel was used to acquire the ultrasound image of the right lobe of the liver (total gain, 15 dB; dynamic range, 65; depth, 3.5 cm). To avoid shadowing of the ribs, the transducer was located in the right intercostal space in parallel as much as possible. The examined region of interest (ROI; size, 5 3 6 mm; depth, 0.5-1.5 cm) was located in the right lobe of the liver, avoiding the interference of the hepatic interlobar fissure and large vessels. Based on a prior study, the standard deviation in the stiffness measurement reduced with increasing measurement times. 8 The median SWV was recorded after 10 measurements for each rat. Then the mean SWV for the 8 rats in each group was recorded. The final data were collected and stored for statistical analysis.
Blood Samples, Liver Specimen Collection, and Analysis On day 28, all of the rats were anaesthetized by intraperitoneal injection of 0.3% pentobarbital sodium (1 mL/ 100 g). A 6-mL arterial blood sample was drawn from the abdominal aorta. The blood was collected for serum ALT and AST analysis by using an XE2100 automatic blood analyzer (Sysmex, Kobe, Japan) and an AU2700 automatic biochemical blood analyzer (Olympus, Tokyo, Japan).
Animals were assessed by pathologic examination during necropsy. The right lobe of the liver was collected and immediately fixed in 4% (vol/vol) formalin, embedded in paraffin blocks, sliced into 3 to 5 lm in thickness, and stained with hematoxylin-eosin. The liver sample was 2 cm away from the surface and overlapped the ROI as much as possible. Two board-certified pathologists observed these slides.
Statistical Analyses
Statistical analyses were performed with SPSS version 17.0 software (IBM Corporation, Armonk, NY). Data were presented as mean 6 standard deviation in a quantitative evaluation. Statistical significance was evaluated by 1-way analysis of variance for quantitative data with the Bonferroni multiple-comparison test, with P < .05 considered significant.
Results
Comparisons of SWVs in Different Groups
The mean SWVs at the 5 time points in this experiment are summarized in Table 1 . The ARFI images of the hepatic SWV in the 100% SiO 2 group collected on the 5 different days are shown in Figure 2 .
There were no significant differences among the control, normal saline, and PPE groups (P > .05) on days 3, 7, 14, 21, and 28. This result showed that polyacrylate and the mechanism of exposure did not contribute to the elevation of hepatic stiffness under the conditions of this study. The differences in SWVs among Figure 2 . Acoustic radiation force impulse images of the hepatic SWV in the 100% SiO2 group on days 3, 7, 14, 21, and 28 (a-e). the 9 groups were insignificant on days 3 and 7 (P > .05; Figure 3 , a and b). From the 14th day, the SWVs of the SiO 2 and SiO 2 /PPE groups were significantly higher than in the control group (P < .05). This result showed that SiO 2 nanoparticles played a key role in the elevation of hepatic stiffness. . a and b, There were no significant differences in the SWV among the 9 groups on days 3 and 7. a-e, There were no significant differences in the SWV among the blank control, normal saline (NS), and PPE groups on days 3, 7, 14, 21, and 28. c, On day 14, the SWVs in the 50% 100% SiO 2 groups were significantly higher than in the control group (P <.05). The SWV in the 100% SiO 2 /PPE group was significantly increased compared with the control group and the 25% and 50% SiO 2 / PPE groups (P <.05). d and e, On days 21 and 28, the SWV in the SiO 2 groups (25%, 50%, and 100%) and SiO 2 /PPE groups (25%, 50%, and 100%) increased compared with the control group (P <.05). The SWVs in the 100% SiO 2 and 100% SiO 2 /PPE groups were highest (P <.05) on day 21. However, there was no significant difference among the 25%, 50%, and 100% SiO 2 groups on day 21 (P >.05).
Shear Wave Velocities by SiO 2 Nanoparticle Dosages in Different Groups
On day 14, the SWVs in the 50% and 100% SiO 2 groups were significantly higher than those in the control and 25% SiO 2 groups (P < .05). In contrast, the 25% SiO 2 group was not significantly different compared with the control group (P > .05). The SWV in the 100% SiO 2 / PPE group was significantly higher than those in the control, 25%, and 50% SiO 2 /PPE groups (Figure 3c ; P < .05). On day 21, the SWV in the 100% SiO 2 /PPE group increased compared with the 25% and 50% SiO 2 / PPE groups (P < .05; Figure 3d ). These results showed that the SiO 2 nanoparticle dosage played a key role in the elevation of liver stiffness; a higher dosage of SiO 2 nanoparticles may cause SWV elevation sharply at a particular time. On day 28, the SWV in the 25% SiO 2 group Figure 4 . Changes in the SWV with the passage of exposure time in the 9 groups.
was elevated compared with the control group (P < .05). Meanwhile, the SWV in the 25% SiO 2 group was the lower than that in the 100% SiO 2 group ( Figure  3e ). This result showed that even the lowest dose of SiO 2 nanoparticles was able to induce an elevation in liver stiffness at an adequate exposure time, and SWVs in the various SiO 2 groups were elevated with increased dosages of SiO 2 nanoparticles. On day 14, the SWV in the 50% SiO 2 group was higher than those in the control group and 50% SiO 2 / PPE groups (P < .05), whereas no significant difference was found between the 50% SiO 2 /PPE and control groups (P > .05). On day 21, the SWV in the 100% SiO 2 /PPE group was higher than that in the 100% SiO 2 group (P < .05). On the basis of these results, we speculated that pure SiO 2 nanoparticles may induce earlier hepatic injury. On the other hand, SiO 2 nanoparticles combined with PPE may induce more severe hepatic injury at a particular time.
Shear Wave Velocities and Increased Exposure Times in the SiO 2 and SiO 2 /PPE Groups With exposure time as the dependent variable, the SWVs in the control group, 25%, 50%, and 100% SiO 2 groups, and 25%, 50%, and 100% SiO 2 /PPE groups are summarized in Table 1 . With the passage of exposure time, the SWVs were significantly elevated in both the SiO 2 and SiO 2 /PPE groups (P < .05), which were distributed from low to high in turn, whereas the control group had no significant change (P > .05; Figure 4 ). We concluded that the SWVs in the SiO 2 and SiO 2 /PPE groups increased with exposure time ( Figure 5 ).
Biochemical Results
The ALT and AST values on day 28 are summarized in Table 2 . Alanine aminotransferase values were elevated in the SiO 2 and SiO 2 /PPE groups (P < .05), which were distributed from low to high in turn, whereas the control, PPE, and normal saline groups had insignificant differences (P > .05). Statistical box plots of serum ALT and AST are shown in Figure 6 .
Correlation of ALT, AST, and SWV on Day 28
On day 28, the ALT and SWV values in the 9 groups were significantly correlated (r 5 .827; P < .05), whereas the AST and SWV values were uncorrelated (r 5 20.040; P > .05).
Histologic Findings
Histologic specimens from the 9 groups after 28 days of exposure are shown in Figure 7 . The hepatic histologic specimens from the control group were normal. Vacuolar degeneration of hepatic cells and structural disorder of hepatic cords were seen in the SiO 2 groups (25%, 50%, and 100%) and SiO 2 /PPE groups (25%, 50%, and 100%), and hepatic apoptosis appeared in the 25% SiO 2 group. Liver pathologic specimens from rats in the 25% SiO 2 group showed periportal inflammatory cells in the central vein (Figure 8 ).
Discussion
Several animal studies have demonstrated that SiO 2 nanoparticles can cause damage to multiple organs, which leads to conditions such as pulmonary fibrosis, pleural effusions, pulmonary granulomas, and various other sequelae. 3, 4 Other animal studies have shown that Figure 5 . Shear wave velocity time-changing curves for the 9 groups. NS indicates normal saline. inhaled nanoparticles were found not only in the lung but also in the blood circulation, liver, kidney, brain, and heart. 9 As one of the most important detoxification organs, the liver is suspected to be a target of inhaled SiO 2 nanoparticles. Whether SiO 2 nanoparticles acquired via respiratory tract inhalation can induce hepatic injury is still a debatable issue. In this study, we proved that inhaled SiO 2 nanoparticles indeed induced hepatic injury in rats on ARFI and histologic examinations. Taken together, our study sheds light on the concept that SiO 2 in polluted air may cause human hepatic injury, which should be of major concern.
Compared with the control group, the normal saline and PPE groups showed negative outcomes for ALT, AST, SWV, and histologic slides during the entire experiment. Hence, we conclude that under the conditions of this study, endotracheal exposure does not cause liver damage, and PPE showed insignificant hepatic toxicity in rats. After 28 days of exposure, the SWVs in the SiO 2 and SiO 2 /PPE groups were significantly higher than in the control group, whereas the PPE group showed negative outcomes. These results showed that SiO 2 nanoparticles played a key role in the elevation of hepatic stiffness. Meanwhile, elevated ALT levels were limited to proving the degree of hepatic injury, as the ALT levels also showed a significant correlation with the SWV on day 28. Therefore, we presumed that the SWV as an indicator of tissue stiffness could reflect the degree of hepatic damage.
Under a light microscope, structural disorder of the hepatic cords and vacuolar degeneration of hepatic cells appeared in the SiO 2 and SiO 2 /PPE groups. These results proved that inhalable SiO 2 nanoparticles indeed induced hepatic injury and furthermore provided an explanation for hepatic stiffness. Ultimately, the change in hepatic stiffness resulted in an elevated SWV. Previous studies have indicated that the SiO 2 particles with a diameter of 70 nm could induce hepatocyte damage in rats, using hydroxyproline as an index of hepatic fibrosis. The hydroxyproline in the high-concentration group was higher than that observed in the control group. 9, 10 However, in this study, hydroxyproline was limited to a serum enzyme indicator, which could not directly reflect morphologic changes in the liver. Since vacuolar degeneration of hepatic cells and structural disorder of the hepatic cords are indices of morphologic changes, our study sought to identify an appropriate indicator that could adequately reflect these changes. Hence, the SWV as an index of human hepatic injury induced by SiO 2 nanoparticles was valuable.
Previous studies have demonstrated that SiO 2 nanoparticles permeated through pulmonary artery barriers and then induced damage to multiple organs by high surface activity, which activated lipid peroxidation and the antioxidant system. [11] [12] [13] In this study, a series of pathologic changes induced by inhalable SiO 2 nanoparticles may have complied with the same mechanism. Inflammatory cell infiltration and hepatic apoptosis were Figure 6 . Serum ALT and AST values in the 9 groups on day 28. a, There was no significant difference in the serum ALT in the blank control, normal saline (NS), and PPE groups. The serum ALT in the SiO 2 and SiO 2 /PPE groups were increased compared with the control group (P <.05). b, There was no significant difference in the serum AST in the 9 groups (P >.05).
also seen on the histologic slides from the SiO 2 exposure groups. Previous studies have shown that hepatic Kupffer cells play a key role in hepatic toxicity induced by nanoparticles. In these studies, Kupffer cells were activated by external stimulation, and the activated cells produced bioactive substances, which induced liver damage. 14, 15 In our study, we observed that mast cells rather than Kupffer cells gathered in the portal area, and apoptosis was shown on the histologic slides from the SiO 2 groups. Whether mast cells are involved in hepatic apoptosis remains unknown and is a direction for future investigations. We speculated that SiO 2 nanoparticles transmitted by multiple inflammatory mediators and cytokines resulted in hepatocyte apoptosis and, ultimately, hepatic cirrhosis. These morphologic changes in the liver were eventually proven by ARFI, which showed an elevated SWV. On the other hand, fibroblast cells and hepatic cirrhosis were not observed on the histologic slides; therefore, we were unable to conclude that inhalable SiO 2 nanoparticles induced hepatic cirrhosis under the conditions of this experiment. However, a previous report demonstrated that oral exposure to SiO 2 nanoparticles could induce fibrosis around the hepatic portal vein, and cirrhosis-related gene expression was evident 84 days later. 16 Therefore, we speculated that inhalable SiO 2 nanoparticles may induce hepatic cirrhosis after prolonged exposure, and the mechanism of exposure may play a key role in hepatic injury. At present, the world is facing a highly complex means of exposure to SiO 2 nanoparticles, and we have revealed the potential value of ARFI for noninvasively evaluating human organs.
Compared with the control group, the SWV in the 50% SiO 2 group was elevated on day 14, whereas the same dosage of SiO 2 in the 50% SiO 2 /PPE group did not increase the SWV. These results illustrated that under the same dosage of SiO 2 nanoparticles, hepatic injury appeared earlier in the pure SiO 2 groups compared with the compound exposure groups. However, there was no statistical difference between the 25% SiO 2 and control groups on day 14. This result showed that the quantity of SiO 2 nanoparticles was one of the important factors in liver injury. On day 21, the SWV in the 25% SiO 2 group was significantly higher than that in the control group; however, there was no statistical difference found between the SiO 2 groups at different concentrations. On day 28, we observed a significantly elevated SWV in the 25% SiO 2 group compared with the control group. Meanwhile, the SWV in the 25% SiO 2 group was lower than that in the 100% SiO 2 group. This result showed that even the lowest dose of SiO 2 nanoparticles could induce an elevation in liver stiffness with an adequate exposure time, and the SWVs in the SiO 2 groups were elevated along with increases in the dosage. Taken together, we concluded that a low dose of SiO 2 nanoparticles over an extended exposure time is adequate to induce liver injury. From this finding, we concluded that the exposure time was another important factor in hepatic injury induced by SiO 2 nanoparticles. With increased exposure time, the SWVs were significantly elevated in similarly concentrated SiO 2 and SiO 2 / PPE groups, which were distributed from low to high in turn, whereas the control group had no significant change. Therefore, we concluded that the hepatic injury induced by SiO 2 nanoparticles was related to dosage and exposure time. The elevation in hepatic stiffness in the higher-dosage SiO 2 groups appeared earlier and was more severe than that in the lower-dosage groups. The histologic sections of the liver tissue and serum ALT results also proved these modifications.
Previous studies showed that SiO 2 nanoparticles were captured by hepatic macrophages (Kupffer cells) after 28 days of exposure, without complete elimination, 17 and SiO 2 nanoparticles led to liver injury related to particle size and quantity (a smaller diameter and higher concentration of SiO 2 nanoparticles showed stronger biological toxicity). Kupffer cells swallowed SiO 2 nanoparticles and then entered into the Disse space, which resulted in the depletion of Kupffer cells and aggregation of reactive oxygen species. Moreover, it has been shown that reactive oxygen species may be the cause of liver cell toxicity. 10, 18 Excessive reactive oxygen species could cause a chain reaction of lipid peroxidation, cell function effects, and denaturation of protein and enzyme deactivation. 19 These reports provide a possible explanation for the occurrence of vacuolar degeneration of hepatic cells and structural disorder of hepatic cords as the main disorders on the histologic slides. Although hepatic apoptosis could be found in the SiO 2 groups, it was not common on the histologic slides. The histologic results may explain the opposite trend of ALT and AST, because ALT mainly exists in the cytoplasm, and AST mainly exists in the mitochondria. Theoretically, the induction of hepatic injury by SiO 2 nanoparticles requires a definitive time to complete the procedure, which entails entrance of the SiO 2 nanoparticles into the body and capture by defense cells, which result in damaged hepatocytes and ultimately leads to the induction of gradual morphologic changes. We speculated that with a longer exposure time or the administration of a higher dosage of SiO 2 nanoparticles, AST would be elevated and result in mitochondrial damage, hepatic apoptosis, which may occur frequently, and then hepatic cirrhosis. This concept was based on the use of ARFI to quantitatively evaluate changes in liver stiffness and our assessment of the time-dose relationship of SiO 2 nanoparticle-induced hepatic damage. In graphic form, the curve was a brief description of the complex processes of SiO 2 nanoparticle-induced hepatic stiffness elevation. The 7th and 14th days were the key points, which was revealed by the SWV, as shown in Figure 5 . The curve indicated that day 7 or 14 would be appropriate to use as an exposure time in future studies for understanding the mechanism of SiO 2 nanoparticle-induced hepatic injury.
On the contrary, PPE combined with SiO 2 nanoparticles induced obvious hepatic stiffness elevations, even in the lower-dosage groups in this study. Relevant studies indicated that smaller-diameter SiO 2 nanoparticles induced stronger toxicity. Small SiO 2 nanoparticles (diameter, 30 nm) had strong synergistic toxicity. 20 We concluded that SiO 2 nanoparticles combined with PPE may show a stronger synergistic toxic effect, which then may induce more serious hepatic injury.
However, we also had limitations in this study. The number of animals in each group was limited, which may have posed a bias influence on the experimental results. The ROI could not completely cover the areas of the histologic samples, although sampling of the hepatic tissues consistent with the ROI was maintained as much as possible. Furthermore, the limited small particulate exposure time was insufficient to observe hepatic cirrhosis; therefore, an extended exposure time will be the focus of future studies. Altogether, the mechanism of silica nanoparticles at the molecular level and hepatic toxicity induced by the particles warrant further investigations.
In summary, our study showed that endotracheal instillation of SiO 2 nanoparticles could induce injury to the livers of rats. Using ARFI, we were able to noninvasively and dynamically observe the SWV changes in the livers of rats, which would provide a theoretical basis for evaluation of hepatic toxicity; the degree of hepatic toxicity was positively correlated with the concentration of inhalable SiO 2 nanoparticles and exposure time.
